Treatment of mice with fenbendazole attenuates allergic airways inflammation and Th2 cytokine production in a model of asthma

Immunology and Cell Biology

Volumn 87, Issue 8, 2009, Pages 623-629

  Cai, Yeping ^a   Zhou, Jiansheng ^a   Webb, Dianne C ^a  

^a Biology and Environment   (Australia)

Author keywords

Allergy; Anthelmintics; Eosinophils; Th2 cytokines

Indexed keywords

CD69 ANTIGEN; FENBENDAZOLE; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG WITHDRAWAL; EXPERIMENTAL MODEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LOEFFLER PNEUMONIA; LYMPH NODE CELL; MALE; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; RESPIRATORY TRACT INFLAMMATION; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD19; ASTHMA; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FENBENDAZOLE; IMMUNOGLOBULIN G; LYMPH NODES; MICE; MICE, INBRED BALB C; TH2 CELLS;

MUS; OXYURIDA;

EID: 70450277312     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.47     Document Type: Article

References (23)

1. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM et al. Predominant Th2-like bronchoalveolar lavage T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
2. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow Jr JC. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109-115.
3. Michels C, Goyal P, Nieuwenhuizen N, Brombacher F. Infection with Syphacia obvelata (pinworm) induces protective Th2 immune responses and influences ovalbumininduced allergic reactions. Infect Immun 2006; 74: 5926-5932.
4. Dawson PJ, Gutteridge WE, Gull K. A comparison of the interaction of anthelmintic benzimidazoles with tubulin isolated from mammalian tissue and the parasitic nematode Ascaridia galli. Biochem Pharmacol 1984; 33: 1069-1074.
5. Reiss CS, Herrman JM, Hopkins RE. Effects of antihelminth treatment on the immune response of mice. Lab Anim Sci 1987; 37: 773-775.
6. Franke DD, Shirwan H. Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice. Int Immunol 2006; 18: 453-458.
7. Dvoroznakova E, Boroskova Z, Dubunsky P, Velebny S, Tomasovicova O, Machnicka B. Changes in cellular immunity of mice treated for laval toxocarosis with fenbendazole. Helminthologica 1998; 35: 189-195.
8. Stankiewicz M, Cabaj W, Jonas WE, Moore LG, Chie WN. Oxfendazole treatment of non-parasitized lambs and its effect on the immune system. Vet Res Commun 1994; 18: 7-18.
9. Cabaj W, Stankiewicz M, Jonas WE, Moore LG. Fenbendazole and its effect on the immune system of the sheep. NZ Vet J 1994; 42: 216-220.
10. Holden HE, Crider PA, Wahrenberg MG. Mitotic arrest by benzimidazole analogs in human lymphocyte cultures. Environ Mutagen 1980; 2: 67-73.
11. Webb DC, Mahalingam S, Cai Y, Matthaei KI, Donaldson DD, Foster PS. Antigenspecific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4ralphaindependent airway hyperreactivity. Eur J Immunol 2003; 33: 3377-3385. (Pubitemid 37541114)
12. Webb DC, McKenzie ANJ, Koskinen AML, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 2000; 165: 108-113.
13. Webb DC, Cai Y, Matthaei KI, Foster PS. Comparative roles of IL-4, IL-13, and IL-4ralpha in dendritic cell maturation and CD4+ Th2 cell function. J Immunol 2007; 178: 219-227.
14. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J Exp Med 1988; 167: 1737-1742.
15. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperrreactivity, and lung damage in mice. Am J Respir Care Med 1998; 157: 210-218.
16. Horie S, Okubo Y, Hossain M, Sato E, Nomura H, Koyama S et al. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern Med 1997; 36: 179-185.
17. Hamelmann E, Oshiba A, Loader J, larsen GL, Gleich G, Lee J et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997; 155: 819-825.
18. Hogan SP, Koskinen A, Foster PS. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 1997; 75: 284-288.
19. Webb DC, Matthaei KI, Cai Y, McKenzie AN, Foster PS. Polymorphisms in IL-4ralpha correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13(-/-) mice. J Immunol 2004; 172: 1092-1098.
20. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmerman N, Matthaei KI et al. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001; 108: 594-601.
21. Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, Zimmermann N et al. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J Biol Chem 2005; 280: 13952-13961.
22. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994; 12: 456-465.
23. Friedman PA, Platzer EG. Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin. Biochim Biophys Acta 1980; 630: 271-278.